Acute renal failure following treatment with intravenous immunoglobulins;Acuut nierfalen na behandeling met intraveneus toegediende immunoglobulinen

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 7, 2003, Pages 307-310

  Van Zanten, A R H ^a   Beekhuyzen, M ^a   Van Der Meer, Y G ^a   De Gooijer, A ^a   Feith, G W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MANNITOL; SUCROSE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG MEGADOSE; FEMALE; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; HUMAN; KIDNEY DYSFUNCTION; LABORATORY TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; ONCOTIC PRESSURE; RISK FACTOR; SENESCENCE; TREATMENT OUTCOME;

EID: 0037442407     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kuwabara S, Mori M, Ogawara K, Hattori T, Oda S, Koga M, et al. Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GMI antibody. Muscle Nerve 2001;24:54-8.
2. Buchwald B, Ahangari R, Weishaupt A, Toyka KV. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Ann Neurol 2002;51:673-80.
3. Kleyweg RP, Meché FGA van der. De ziekte van Guillain-Barré: een nieuwe behandelingsmethode met immunoglobulinen. Ned Tijdschr Geneeskd 1992;136:1956-60.
4. Gaines A, Varricchio F, Kapit R, Pierce LR, Scott D, Finlayson J. Renal insufficiency and failure associated with immune globulin intravenous therapy - United States, 1985-1998. MMWR Morb Mortal Wkly Rep 1999;48:518-21.
5. Windrum P, Bharucha C, Desai ZR. Intravenous immunoglobulin therapy and renal dysfunction. Br J Haematol 1998;101:592.
6. Brannagan 3rd TH, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 1996;47:674-7.
7. Ahsan N. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy. J Nephrol 1998;11:157-61.
8. Stahl M, Schifferli JA. The renal risks of high-dose intravenous immunoglobulin treatment. Nephrol Dial Transplant 1998;13:2182-5.
9. Tan E, Hajinazarian M, Bay W, Neff J, Mendell JR. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993;50:137-9.
10. Cantu TG, Hoehn-Saric EW, Burgess KM, Racusen L, Scheel PJ. Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis 1995;25:228-34.
11. Haskin JA, Warner DJ, Blank DU. Acute renal failure after large doses of intravenous immune globulin. Ann Pharmacother 1999;33:800-3.
12. Sati HI, Ahya R, Watson HG. Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy. Br J Haematol 2001;113:556-7.
13. McColl MD, Omran A, Walker ID, Lowe GDO. Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia. Haemophilia 1999;5:124-6.
14. Levy JB, Pusey CD. Nephrotoxicity of intravenous immunoglobulin. QJM 2000;93:751-5.
15. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6.